Astrana Health (NASDAQ:ASTH) Research Coverage Started at KeyCorp

KeyCorp assumed coverage on shares of Astrana Health (NASDAQ:ASTH) in a report released on Friday, Marketbeat.com reports. The firm issued a sector weight rating on the stock.

ASTH has been the subject of a number of other research reports. BTIG Research lifted their price objective on Astrana Health from $60.00 to $70.00 and gave the company a buy rating in a research note on Thursday, October 3rd. Robert W. Baird lifted their price target on Astrana Health from $54.00 to $67.00 and gave the stock an outperform rating in a research report on Thursday, August 15th. Stifel Nicolaus increased their price objective on shares of Astrana Health from $48.00 to $60.00 and gave the company a buy rating in a research report on Thursday, August 1st. Finally, Truist Financial lifted their target price on shares of Astrana Health from $50.00 to $59.00 and gave the stock a buy rating in a report on Friday, August 9th. One investment analyst has rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Astrana Health currently has a consensus rating of Buy and a consensus target price of $61.20.

Astrana Health Stock Down 1.3 %

NASDAQ:ASTH opened at $56.23 on Friday. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.84 and a quick ratio of 1.84. The firm’s 50-day moving average price is $51.76 and its 200-day moving average price is $45.22. The company has a market capitalization of $3.15 billion, a PE ratio of 42.60, a P/E/G ratio of 2.20 and a beta of 1.21. Astrana Health has a 1-year low of $28.86 and a 1-year high of $61.51.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.01. Astrana Health had a net margin of 4.30% and a return on equity of 10.71%. The business had revenue of $486.30 million for the quarter, compared to analysts’ expectations of $440.68 million. During the same quarter in the prior year, the company earned $0.28 earnings per share. The business’s revenue was up 39.7% compared to the same quarter last year. On average, equities analysts predict that Astrana Health will post 1.33 EPS for the current fiscal year.

Institutional Investors Weigh In On Astrana Health

Large investors have recently bought and sold shares of the business. GAMMA Investing LLC purchased a new stake in Astrana Health in the third quarter worth approximately $34,000. Handelsbanken Fonder AB bought a new stake in shares of Astrana Health during the 3rd quarter valued at about $492,000. Granite Bay Wealth Management LLC bought a new stake in shares of Astrana Health during the 3rd quarter valued at about $290,000. SG Americas Securities LLC purchased a new stake in shares of Astrana Health during the 3rd quarter valued at about $680,000. Finally, Central Pacific Bank Trust Division bought a new position in shares of Astrana Health in the 3rd quarter worth approximately $160,000. 52.77% of the stock is currently owned by institutional investors.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.